Featured News

GHTC honored Congresswoman Anna Eshoo (D-CA) and Congressman Mario Diaz-Balart (R-FL) and the developers of the RTS,S malaria vaccine at its 2019 Innovating for Impact Awards, an initiative celebrating the US policymakers and partnerships driving global health innovation.

Learn More

PATH/Eric Becker
GHTC joins sign-on letter urging swift passage of FY20 appropriations bills to avoid negative consequences for science and research

GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”

PDF

GHTC
Homeland Preparedness News covers GHTC awards

Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).

View

Representatives Anna Eshoo and Mario Diaz-Balart and developers of the RTS,S malaria vaccine honored with GHTC Innovating for Impact Awards
GHTC yesterday honored Congresswoman Anna Eshoo (D-CA) and Congressman Mario Diaz-Balart (R-FL) for their leadership in supporting global health research and development (R&D) at its 2019 Innovating for Impact Awards, an initiative celebrating the US policymakers and partnerships driving global health innovation. GHTC also recognized the partnership that developed the RTS,S malaria vaccine—the world’s first malaria vaccine—for its efforts to advance this breakthrough technology.
Learn More

USAID
GHTC sends letter urging Congressional appropriators to include report language on BARDA in F20 bill

GHTC sent a letter to House and Senate appropriators urging them to include in the final fiscal year (FY) 2020 Labor, Health and Human Services, Education, and Related Agencies bill report language emphasizing the role of the Biomedical Advanced Research and Development Authority (BARDA) in advancing R&D for naturally-occurring health threats and requesting a delineation of BARDA’s investments in this area in its annual five-year budget plan. 

PDF

PATH/Gabe Bienczycki
GHTC responds to RFI on National Vaccine Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI) on the 2020 National Vaccine Action Plan (NVP). GHTC’s submission encouraged the continuation of R&D objectives reflected in the 2010 NVP and recommended additional areas of focus including strengthening public-private partnerships, advancing regulatory science, ensuring sustainable financing for areas that lack commercial market demand, promoting access-centered R&D, and collaborating with international partners to strengthen laboratory and clinical trial capacity.

PDF
View All News

Representatives Anna Eshoo and Mario Diaz-Balart and developers of the RTS,S malaria vaccine honored with GHTC Innovating for Impact Awards
GHTC yesterday honored Congresswoman Anna Eshoo (D-CA) and Congressman Mario Diaz-Balart (R-FL) for their leadership in supporting global health research and development (R&D) at its 2019 Innovating for Impact Awards, an initiative celebrating the US policymakers and partnerships driving global health innovation. GHTC also recognized the partnership that developed the RTS,S malaria vaccine—the world’s first malaria vaccine—for its efforts to advance this breakthrough technology.
Learn More

CDC/James Gathany
GHTC Statement on the Okayama Declaration of the G20 Health Ministers Meeting

The Global Health Technologies Coalition is greatly encouraged that yesterday’s Okayama Declaration from G20 Health Ministers contains strong support for investing in research and development initiatives to combat antimicrobial resistance and improve public health preparedness.

Learn More

PATH
US FDA Approves New TB Drug in Treatment to Cure Practically Incurable XDR-TB

Statement from Jamie Bay Nishi, Director, Global Health Technologies Coalition, on the US Food and Drug Administration’s approval of pretomanid, a new drug developed by the nonprofit TB Alliance.

Learn More

PATH/Mike Wang
President Signs Bill Reinforcing Fight Against Disease Threats. Focus Now Turns to Funding.

This legislation is an important step forward in strengthening our nation’s preparedness against global disease threats. We applaud the Administration and Congress for recognizing that protecting our nation’s health requires deploying BARDA’s unique capabilities to combat all hazards—not only chemical, biological, radiological and nuclear threats, but naturally occurring health threats as well.

View

GHTC
GHTC opens call for nominations for 2019 Innovating for Impact Awards

GHTC has opened nominations for its 2019 Innovating for Impact Awards. Now in its third year, this initiative celebrates the partnerships and policymakers driving global health innovation. The nomination deadline is July 31, 2019.

Learn More
View All Announcements
PATH/Gabe Bienczycki
A year in review: The global health innovation stories that shaped 2019

As the year comes to a close, we are taking a look back at the top global health innovation stories and news that shaped 2019.

Read More
PATH/Patrick McKern
Research Roundup: Once-a-month birth control pill, experimental typhoid fever vaccine, and release of 2019 World Malaria Report

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Mike Wang
Research Roundup: child-friendly HIV drugs, trial shows two Ebola treatments significantly reduce mortality, and study shows for babies born with HIV to start treatment right away

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
GHTC
Faces of Innovation: Hannah Wu, researcher at Brown University

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Hannah Wu, who we met at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference, who is working to develop vaccines against the neglected tropical disease schistosomiasis at Brown University.

Read More
PATH/Matthew Dakin
Explainer: the Nagoya Protocol and its impact on global health R&D

The World Health Organization recently announced that at its upcoming Executive Board meeting in February member states will discuss challenges and issues in implementing the Nagoya Protocol—a legal framework that governs the access to and benefits gained through the sharing of genetic resources including human and animal DNA, plants, and pathogens. As these discussions heat up, GHTC is taking a brief look at what the Nagoya Protocol is, how it impacts global health R&D, and what’s next for the future of this framework.

GHTC
Read More
View Breakthroughs Blog

GHTC
Homeland Preparedness News covers GHTC awards

Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).

View

PATH/Matthew Dakin
GHTC op-ed featured in The Hill

A commentary piece authored by GHTC Director Jamie Bay Nishi on the steady and substantial funding necessary to drive breakthrough innovations for global health threats was featured in The Hill

View

PATH/Wendy Stone
GHTC Director quoted in The Hill on Ebola vaccine development

The Hill quoted GHTC Director Jamie Bay Nishi in an article on Ebola vaccine development. 

View

PATH/Wendy Stone
GHTC Director quoted in The Verge on product development for emerging and infectious diseases

The Verge quoted GHTC Director Jamie Bay Nishi in an article on developing drugs and products amidst an outbreak.

View

PATH/Katrina Peach
GHTC Director quoted in CIDRAP on FDA approval of a new drug for highly resistant tuberculosis

CIDRAP quoted GHTC Director Jamie Bay Nishi in an article on the FDA approval of a new drug to treat highly resistant tuberculosis.

View
View All GHTC in the Media

PATH/Eric Becker
GHTC joins sign-on letter urging swift passage of FY20 appropriations bills to avoid negative consequences for science and research

GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”

PDF

USAID
GHTC sends letter urging Congressional appropriators to include report language on BARDA in F20 bill

GHTC sent a letter to House and Senate appropriators urging them to include in the final fiscal year (FY) 2020 Labor, Health and Human Services, Education, and Related Agencies bill report language emphasizing the role of the Biomedical Advanced Research and Development Authority (BARDA) in advancing R&D for naturally-occurring health threats and requesting a delineation of BARDA’s investments in this area in its annual five-year budget plan. 

PDF

PATH/Gabe Bienczycki
GHTC responds to RFI on National Vaccine Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI) on the 2020 National Vaccine Action Plan (NVP). GHTC’s submission encouraged the continuation of R&D objectives reflected in the 2010 NVP and recommended additional areas of focus including strengthening public-private partnerships, advancing regulatory science, ensuring sustainable financing for areas that lack commercial market demand, promoting access-centered R&D, and collaborating with international partners to strengthen laboratory and clinical trial capacity.

PDF

National Institute of Allergy and Infectious Diseases, National Institutes of Health
GHTC endorses letter urging robust funding for NIH in FY20 appropriations bill

GHTC endorsed a letter from the Ad Hoc Group for Medical Research urging House and Senate appropriators to work quickly to adopt a meaningful increase to the fiscal year 2020 (FY20) Labor, Health and Human Services, Education, and Related Agencies appropriations bill and provide a robust funding increase for the National Institutes of Health.

PDF

PATH/Ruhani Kaur
GHTC endorses letter calling for robust TB funding in FY20 appropriations bill

GHTC endorsed a letter from the TB Roundtable to House and Senate appropriators urging the adoption of robust funding levels for tuberculosis (TB) programs at the US Agency for International Development and Centers for Disease Control and Prevention in final fiscal year 2020 (FY20) appropriations bills. The letter also urges appropriators to restore TB as a disease eligible for funding under the Department of Defense’s Peer Reviewed Medical Research Program.

PDF
View All Advocacy Actions

Events

Community Event

PATH/Lesley Reed
12th Annual Center for Emerging & Neglected Diseases Symposium
Henry Wheeler Center for Emerging and Neglected Diseases (CEND)
Learn More

Community Event

PATH/Gabe Bienczycki
19th International Congress on Infectious Diseases
International Society for Infectious Diseases and Malaysian Society of Infectious Diseases & Chemotherapy
Learn More
View All Current & Past Events

Stay Informed

Sign up to receive news and updates from GHTC.
Sign Up Now

Media Inquiries

Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
mchmiola@ghtcoalition.org